MA58793B1 - Compositions topiques conçues pour maintenir et/ou restaurer l'intégrité de la muqueuse et de l'épiderme endommagé - Google Patents
Compositions topiques conçues pour maintenir et/ou restaurer l'intégrité de la muqueuse et de l'épiderme endommagéInfo
- Publication number
- MA58793B1 MA58793B1 MA58793A MA58793A MA58793B1 MA 58793 B1 MA58793 B1 MA 58793B1 MA 58793 A MA58793 A MA 58793A MA 58793 A MA58793 A MA 58793A MA 58793 B1 MA58793 B1 MA 58793B1
- Authority
- MA
- Morocco
- Prior art keywords
- epdermis
- restore
- integrity
- maintain
- topical compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 210000004877 mucosa Anatomy 0.000 title 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 1
- 239000008777 Glycerylphosphorylcholine Substances 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- -1 ascorbic acid ester Chemical class 0.000 abstract 1
- 229960004788 choline alfoscerate Drugs 0.000 abstract 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-O glycerylphosphorylcholine Chemical compound C[N+](C)(C)CCO[P@](O)(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-O 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 230000003232 mucoadhesive effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
L'invention concerne des compositions mucoadhésives topiques comprenant de l'acide hyaluronique ou un sel de celui-ci, du choline alfoscerate, un ester d'acide ascorbique à une concentration comprise entre 0,050 % p/p et 0,0004 % p/p, et au moins un excipient ou support pharmaceutiquement acceptable.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102020000004069A IT202000004069A1 (it) | 2020-02-27 | 2020-02-27 | Composizioni topiche per il mantenimento e/o ripristino dell’integrità delle mucose e dell’epidermide lesa |
| PCT/IB2021/051573 WO2021171215A1 (fr) | 2020-02-27 | 2021-02-25 | Compositions topiques conçues pour maintenir et/ou restaurer l'intégrité de la muqueuse et de l'épiderme endommagé |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA58793B1 true MA58793B1 (fr) | 2024-04-30 |
Family
ID=70738958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA58793A MA58793B1 (fr) | 2020-02-27 | 2021-02-25 | Compositions topiques conçues pour maintenir et/ou restaurer l'intégrité de la muqueuse et de l'épiderme endommagé |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US20230114487A1 (fr) |
| EP (1) | EP4110288B1 (fr) |
| JP (1) | JP7713242B2 (fr) |
| KR (1) | KR20220146582A (fr) |
| CN (1) | CN115209873A (fr) |
| AU (1) | AU2021225476B2 (fr) |
| BR (1) | BR112022016597A2 (fr) |
| CA (1) | CA3169514A1 (fr) |
| CL (1) | CL2022002324A1 (fr) |
| CO (1) | CO2022010763A2 (fr) |
| DK (1) | DK4110288T3 (fr) |
| ES (1) | ES2986010T3 (fr) |
| FI (1) | FI4110288T3 (fr) |
| HR (1) | HRP20240784T1 (fr) |
| HU (1) | HUE066958T2 (fr) |
| IL (1) | IL295822A (fr) |
| IT (1) | IT202000004069A1 (fr) |
| LT (1) | LT4110288T (fr) |
| MA (1) | MA58793B1 (fr) |
| MX (1) | MX428861B (fr) |
| MY (1) | MY210387A (fr) |
| PE (1) | PE20221833A1 (fr) |
| PH (1) | PH12022552115A1 (fr) |
| PL (1) | PL4110288T3 (fr) |
| PT (1) | PT4110288T (fr) |
| RS (1) | RS65451B1 (fr) |
| SI (1) | SI4110288T1 (fr) |
| SM (1) | SMT202400226T1 (fr) |
| WO (1) | WO2021171215A1 (fr) |
| ZA (1) | ZA202210572B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202400003238A1 (it) * | 2024-02-15 | 2025-08-15 | Ricerfarma Srl | Compressa orale mucoadesiva per il trattamento sintomatico della xerostomia, delle afte e delle infiammazioni del cavo orale |
| ES3072372A1 (es) * | 2024-12-27 | 2026-07-01 | Laboratorios Vinas S A | Composición galénica de uso tópico, método de preparación y uso de la misma para el tratamiento de trastornos vulvares |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH683671A5 (it) | 1992-03-30 | 1994-04-29 | Golgi Sa | Uso topico di glicerofosfolipidi deacilati. |
| ITMI20020756A1 (it) * | 2002-04-09 | 2003-10-09 | Sinclair Pharma S R L | Composizioni farmaceutiche topiche per il trattamento delle dermatiti |
| DE102004002001A1 (de) * | 2004-01-14 | 2005-08-11 | Reinmüller, Johannes, Dr.med. | Mittel zur Behandlung von entzündlichen Erkrankungen |
| US20070196311A1 (en) * | 2006-02-21 | 2007-08-23 | Gross Dennis F | Methods and kits for topical administration of hyaluronic acid |
| FR2946252B1 (fr) * | 2009-06-08 | 2011-07-29 | Fabre Pierre Dermo Cosmetique | Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques |
| IT1402907B1 (it) * | 2010-11-30 | 2013-09-27 | Ricerfarma Srl | Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose. |
-
2020
- 2020-02-27 IT IT102020000004069A patent/IT202000004069A1/it unknown
-
2021
- 2021-02-25 SI SI202130135T patent/SI4110288T1/sl unknown
- 2021-02-25 ES ES21714664T patent/ES2986010T3/es active Active
- 2021-02-25 MY MYPI2022004074A patent/MY210387A/en unknown
- 2021-02-25 CN CN202180017478.3A patent/CN115209873A/zh active Pending
- 2021-02-25 PT PT217146646T patent/PT4110288T/pt unknown
- 2021-02-25 PE PE2022001497A patent/PE20221833A1/es unknown
- 2021-02-25 EP EP21714664.6A patent/EP4110288B1/fr active Active
- 2021-02-25 IL IL295822A patent/IL295822A/en unknown
- 2021-02-25 KR KR1020227033288A patent/KR20220146582A/ko active Pending
- 2021-02-25 AU AU2021225476A patent/AU2021225476B2/en active Active
- 2021-02-25 PL PL21714664.6T patent/PL4110288T3/pl unknown
- 2021-02-25 HR HRP20240784TT patent/HRP20240784T1/hr unknown
- 2021-02-25 HU HUE21714664A patent/HUE066958T2/hu unknown
- 2021-02-25 PH PH1/2022/552115A patent/PH12022552115A1/en unknown
- 2021-02-25 BR BR112022016597A patent/BR112022016597A2/pt unknown
- 2021-02-25 WO PCT/IB2021/051573 patent/WO2021171215A1/fr not_active Ceased
- 2021-02-25 FI FIEP21714664.6T patent/FI4110288T3/fi active
- 2021-02-25 MA MA58793A patent/MA58793B1/fr unknown
- 2021-02-25 DK DK21714664.6T patent/DK4110288T3/da active
- 2021-02-25 CA CA3169514A patent/CA3169514A1/fr active Pending
- 2021-02-25 MX MX2022010645A patent/MX428861B/es unknown
- 2021-02-25 JP JP2022550124A patent/JP7713242B2/ja active Active
- 2021-02-25 US US17/904,957 patent/US20230114487A1/en not_active Abandoned
- 2021-02-25 SM SM20240226T patent/SMT202400226T1/it unknown
- 2021-02-25 LT LTEPPCT/IB2021/051573T patent/LT4110288T/lt unknown
- 2021-02-25 RS RS20240458A patent/RS65451B1/sr unknown
-
2022
- 2022-07-29 CO CONC2022/0010763A patent/CO2022010763A2/es unknown
- 2022-08-25 CL CL2022002324A patent/CL2022002324A1/es unknown
- 2022-09-23 ZA ZA2022/10572A patent/ZA202210572B/en unknown
-
2023
- 2023-09-29 US US18/477,609 patent/US12251398B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108678T1 (el) | Υγρα σκευασματα για την προληψη και αντιμετωπιση βλεννογονικων νοσων και διαταραχων | |
| MA26901A1 (fr) | Nouvelle composition pharmaceutique | |
| WO2003105800A3 (fr) | Forme galenique, se presentant sous forme de film adherant a la muqueuse, pour l'administration de principes actifs du cannabis | |
| MA49628B1 (fr) | Processus pour la purification de l'acide hyaluronique | |
| NO20082498L (no) | Diarylurea for behandling av pulmonar hypertensjon | |
| EP4566629A3 (fr) | Utilisation d'un échange de plasma à faible volume pour le traitement de la maladie d'alzheimer dans des stades précoces et intermédiaires | |
| PE20200402A1 (es) | Uso novedoso de un agonista del receptor 2 de formil peptido/receptor a4de lipoxina (fpr2/alx) para el tratamiento de la insuficiencia cardiaca | |
| WO2020208418A8 (fr) | Compositions et procédés pour le traitement d'inconfort des lentilles de contact | |
| AR127533A1 (es) | INHIBIDORES DEL SARS-CoV-2 PARA EL TRATAMIENTO DE INFECCIONES POR CORONAVIRUS | |
| ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
| MA35158B1 (fr) | Formulations topiques de type suspension comprenant un depsipeptide cyclique | |
| ZA202308388B (en) | Nasal compositions comprising alcaftadine | |
| ZA202210572B (en) | Topical compositions designed to maintain and/or restore the integrity of the mucosa and damaged epidermis | |
| MX2022007175A (es) | Compuestos y su uso para el tratamiento de la deficiencia de a1-antitripsina. | |
| EA201591435A1 (ru) | Новая композиция соединения ацетаминофена без побочного эффекта на печень | |
| AR106691A1 (es) | Formulaciones oftálmicas de escualamina | |
| DE69928806D1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
| UA42719C2 (uk) | Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб | |
| AR126552A1 (es) | Composición farmacéutica para prevenir o tratar la esclerosis sistémica | |
| ZA202203563B (en) | Pediatric suspension formulation | |
| ES2186092T3 (es) | Bastidor de laminacion con cilidros cruzados regulables. | |
| EA202192541A1 (ru) | Фармацевтическая композиция для местного применения в виде водного геля, содержащая, по меньшей мере, амитриптилин | |
| MX2023003095A (es) | Composiciones antivirales topicas que comprenden acido hialuronico y carragenina. | |
| MA53521B1 (fr) | Nouveaux composés inhibiteurs de la protéase mpro et de la réplication du sars-cov2, leurs formulations et applications | |
| FR3101539B1 (fr) | Produit de combinaison pour soulager les bronches |